5 min read
Successful DMC Services for Complex Hematologic Cancer Trial
Learn how Veristat's expert biostatistics team worked with a longstanding global biopharma sponsor to navigate complex Data Monitoring Committee (DMC) requirements for a challenging hematologic cancer trial. Collaborative efforts led to successful trial progression and maintained data integrity throughout all study phases.
A global biopharmaceutical company specializing in cell therapies contacted Veristat for support with an ongoing Phase 3 clinical trial for the treatment of relapsed refractory multiple myeloma. The study aimed to establish the efficacy and safety of their novel therapy in over 500 patients with this aggressive form of blood cancer.
In this piece, learn how Veristat's multidisciplinary team was able to work with the sponsor to solve challenges across numerous areas including:
- Complex statistical design and analysis requirements
- Intensive DMC reporting and communication needs
- Multiple interim analyses and sample size re-estimation
Get the Latest News
Categories
- Regulatory Consulting (125)
- Regulatory Submissions (120)
- Clinical Trial Regulations (110)
- COVID-19 (46)
- Strategic Consulting (35)
- Clinical Trials (24)
- Life At Veristat (21)
- Events (16)
- Oncology (13)
- Success Stories (13)
- Project Management (11)
- Decentralized Trials/Virtual Trials (9)
- Medical Writing (9)
- Clinical Operations/Monitoring (8)
- Full-Service (7)
- CMC (6)
- Data Management (5)
- Marketing Applications (5)
- Adaptive Design (4)
- Statistics and Programming (4)
- Biologics (3)
- Cell Gene and RNA (3)
- Biometrics (2)
- Natural History (2)
- Rare Diseases (1)
6 min read
Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support
May 7, 2025 Veristat Events